☆ 4.7 Letter

The arrival of SARS-CoV-2-neutralizing antibodies in a currently avail- able commercial immunoglobulin

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Get Full Text
Add to Collection

Journal

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 149, Issue 6, Pages 1958-1959

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2022.03.026

Keywords

-

Categories

Allergy Immunology

Funding

  1. National Institutes of Health [HHSN272201600013C, AI134907, AI145617, UL1TR001439]
  2. Sealy & Smith Foundation
  3. Kleberg Foundation
  4. John S. Dunn Foundation
  5. Amon G. Carter Foundation
  6. Gillson-Longenbaugh Foundation
  7. Summer-field Roberts Foundation

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.